SYSTEMATIC REVIEW article
Front. Oncol.
Sec. Molecular and Cellular Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1569651
Lactylation And Its Roles in Diseases: A Systematic Bibliometric Exploration of the Research Landscape
Provisionally accepted
- Xinjiang Medical University, Ürümqi, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Lactylation, a post-translational modification (PTM), has gained attention for its role in disease pathogenesis, particularly in cancer and immune regulation. Initially viewed as a glycolysis byproduct, lactate is now recognized as a precursor for histone lysine lactylation (Kla), which regulates gene transcription and epigenetic processes. Dysregulation of lactylation is linked to malignancies, inflammation, and metabolic diseases. Despite growing research, a systematic bibliometric analysis of lactylation remains absent. This study addresses this gap by analyzing lactylation research from 2019 to 2024, focusing on its disease-related mechanisms and therapeutic potential.Method: Data were extracted from the Web of Science Core Collection (2019-2024), yielding 198 relevant articles after screening. Bibliometric analysis was conducted using Microsoft Excel, VOSviewer, Scimago Graphica and CiteSpace. Excel tracked publication trends, VOSviewer generated author density maps, and CiteSpace visualized collaboration networks, co-cited references, and keyword clusters. Scimago Graphica generated Map of country cooperation networks. The study identified research trends, collaborative patterns, and emerging hotspots in lactylation research.Result: Lactylation research has surged exponentially since 2022, with China as the primary contributor (92.42% of publications). Dominant keywords converge on lactylation's role as a direct epigenetic regulator of gene activation, enabling transcriptional reprogramming in diseases; Lactylation drives bladder cancer progression via immunosuppressive genes, mediates myoblast differentiation for muscle repair, and disrupts signaling through non-histone targets; Emerging focus on "differentiation" and "metabolic regulation" highlights its potential as a cellular reprogramming target, crucial for advancing regenerative medicine and combating inflammation-linked pathologies.This study provides the first bibliometric analysis of lactylation research, highlighting its rapid growth and global significance. China leads the field, with extensive contributions from its institutions. Lactylation's role in disease mechanisms, particularly cancer and immune regulation, underscores its therapeutic potential. Emerging research on differentiation and metabolic regulation offers new directions for future studies. Further investigation into lactylation's molecular mechanisms and therapeutic applications is essential for advancing disease diagnosis and treatment.
Keywords: Lactylation (Kla), histone, Cancer, Citespace, VOSviewer, bibliometric analysis
Received: 01 Feb 2025; Accepted: 16 Jun 2025.
Copyright: © 2025 Li, Liu, Jiang, Zhang, Nan, Liu and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yangyang Han, Xinjiang Medical University, Ürümqi, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.